Efficacy and safety of abatacept in a patient with rheumatoid arthritis and concomitant Staphylococcus aureus osteomyelitis

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):947-8. Epub 2015 Oct 30.

Authors

J Sota¹, A Vitale¹, G Lopalco², F Iannone², M Galeazzi¹, L Cantarini³

Affiliations

¹ Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy.
² Interdisciplinary Department of Medicine, Rheumatology Unit, Policlinico of Bari, Italy.
³ Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy. [email protected].

PMID: 26517199

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Abatacept / administration & dosage*
Aged
Anti-Bacterial Agents / administration & dosage
Antirheumatic Agents / administration & dosage
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / diagnosis
Drug Monitoring
Female
Humans
Levofloxacin / administration & dosage*
Osteomyelitis* / diagnosis
Osteomyelitis* / drug therapy
Osteomyelitis* / microbiology
Osteomyelitis* / physiopathology
Radiography
Staphylococcus aureus / drug effects
Staphylococcus aureus / isolation & purification
Toes* / diagnostic imaging
Toes* / pathology
Treatment Outcome

Substances

Anti-Bacterial Agents
Antirheumatic Agents
Levofloxacin
Abatacept